Skip to main content

What the FDA labels say about taking them together

Cyclosporine and rimegepant

Rimegepant's FDA label of June 4, 2026 names cyclosporine in its drug interactions section; the cyclosporine labels PlainMeds reads (4) do not name rimegepant. The rimegepant label: “Concomitant administration of NURTEC ODT with potent inhibitors of P-gp may result in increased exposure of rimegepant.”

Check it at the source: the cyclosporine FDA label on DailyMed (effective August 10, 2026, Novartis Pharmaceuticals Corporation); the rimegepant FDA label on DailyMed (effective June 4, 2026, Pfizer Laboratories Div Pfizer Inc).

What does the cyclosporine label say about rimegepant?

Cyclosporine's label (effective August 10, 2026) and its 3 other brand-application labels do not name rimegepant in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Neoral), Novartis Pharmaceuticals Corporation, effective August 10, 2026 (SPL set 94461af3-11f1-4670-95d4-2965b9538ae3), via openFDA; the full label on DailyMed

What does the rimegepant label say about cyclosporine?

Rimegepant label, drug interactions

Concomitant administration of NURTEC ODT with potent inhibitors of P-gp (e.g., amiodarone, cyclosporine, lapatinib, quinidine, ranolazine) may result in increased exposure of rimegepant.

Source: FDA drug label (NURTEC ODT), Pfizer Laboratories Div Pfizer Inc, effective June 4, 2026 (SPL set 9ef08e09-1098-35cc-e053-2a95a90a3e1d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

14Cyclosporine generic labelers
0Rimegepant generic labelers
CyclosporineRimegepant
Labeled forOrgan transplant rejection, Rheumatoid arthritisMigraine
Boxed warningYesNo
Pharmacy cost (NADAC)$1.04 per unit 0.05% eye emulsion$128.67 per tablet 75 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?